Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives
Gastrointestinal Disorders · 10.05.2024 · 6 (2) · 446-460
DOI: 10.3390/gidisord6020030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastrointestinal Disorders, online erschienen am 10.05.2024. Verfasst von Walter Giordano und 8 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) represents a heterogenous and complex group of idiopathic chronic inflammatory conditions affecting the gastrointestinal tract and other extraintestinal systems with rising global incidences. The interplay of genetic predisposition and environmental factors contributes to its pathogenesis. Among the key cytokines implicated in IBD molecular alterations, IL-33 stands out for its multifaceted roles in both pathogenesis and repair mechanisms. IL-33, known for its action in initiating immune responses, is closely associated with Th2 immunity and is considered a potent inflammatory factor with dual functions, acting both as a pro-inflammatory cytokine and a transcriptional regulator. Primarily expressed by non-hematopoietic cells in the gastrointestinal tract, IL-33 interacts with its receptor, ST2, to modulate immune responses. In IBD, dysregulated IL-33 expression exacerbates mucosal inflammation, compromising barrier integrity and promoting tissue damage and fibrosis. Additionally, IL-33 plays a complex role in IBD-related colorectal cancer (CRC), affecting tumor progression and angiogenesis. This review summarizes the multifaceted roles of IL-33 in gastrointestinal health and disease, emphasizing its significance in the pathogenesis of IBD and CRC. Moreover, we thought it of interest to provide new insights into potential therapeutic avenues targeting IL-33 signaling for the management of these debilitating conditions.
Zitieren
APA
Giordano, W., Ricciardi, G., Casciaro, M., Fiorentino, V., Pizzimenti, C., Viola, A., Martini, M., Tuccari, G., & Ieni, A. (2024). Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives. Gastrointestinal Disorders, 6(2), 446-460. https://doi.org/10.3390/gidisord6020030
Vancouver
Giordano W, Ricciardi G, Casciaro M, Fiorentino V, Pizzimenti C, Viola A, et al. Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives. Gastrointestinal Disorders. 2024;6(2):446-460. doi:10.3390/gidisord6020030
BibTeX
@article{Giordano2024,
author = {Giordano, Walter and Ricciardi, Gabriele and Casciaro, Marco and Fiorentino, Vincenzo and Pizzimenti, Cristina and Viola, Anna and Martini, Maurizio and Tuccari, Giovanni and Ieni, Antonio},
title = {Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives},
journal = {Gastrointestinal Disorders},
year = {2024},
volume = {6},
number = {2},
pages = {446--460},
doi = {10.3390/gidisord6020030}
}
EUVIMED